Background: Varicella zoster virus (VZV) can present as a myelopathy with spinal astrocyte infection. Recent studies support a role for the neurokinin-1 receptor (NK-1R) in virus infections, as well as for cytoskeletal alterations that may promote viral spread. Thus, we examined the role of NK-1R in VZV-infected primary human spinal astrocytes (HA-sps) to shed light on the pathogenesis of VZV myelopathy. Methods: Mock- and VZV-infected HA-sps were examined for substance P (subP) production, NK-1R localization, morphological changes, and viral spread in the presence or absence of the NK-1R antagonists aprepitant and rolapitant. Results: VZV infection of HA-sps induced nuclear localization of full-length and truncated NK-1R in the absence of the endogenous ligand, subP, and was associated with extensive lamellipodia formation and viral spread that was inhibited by NK-1R antagonists. Conclusions: We have identified a novel, subP-independent, proviral function of nuclear NK-1R associated with lamellipodia formation and viral spread that is distinct from subP-induced NK-1R cell membrane/cytoplasmic localization without lamellipodia formation. These results suggest that binding of a putative viral ligand to NK-1R produces a dramatically different NK-1R downstream effect than binding of subP. Finally, the NK-1R antagonists aprepitant and rolapitant provide promising alternatives to nucleoside analogs in treating VZV infections, including myelopathy.
Background: Varicella zoster virus (VZV) can present as a myelopathy with spinal astrocyte infection. Recent studies support a role for the neurokinin-1 receptor (NK-1R) in virus infections, as well as for cytoskeletal alterations that may promote viral spread. Thus, we examined the role of NK-1R in VZV-infected primary human spinal astrocytes (HA-sps) to shed light on the pathogenesis of VZV myelopathy. Methods: Mock- and VZV-infected HA-sps were examined for substance P (subP) production, NK-1R localization, morphological changes, and viral spread in the presence or absence of the NK-1R antagonists aprepitant and rolapitant. Results:VZV infection of HA-sps induced nuclear localization of full-length and truncated NK-1R in the absence of the endogenous ligand, subP, and was associated with extensive lamellipodia formation and viral spread that was inhibited by NK-1R antagonists. Conclusions: We have identified a novel, subP-independent, proviral function of nuclear NK-1R associated with lamellipodia formation and viral spread that is distinct from subP-induced NK-1R cell membrane/cytoplasmic localization without lamellipodia formation. These results suggest that binding of a putative viral ligand to NK-1R produces a dramatically different NK-1R downstream effect than binding of subP. Finally, the NK-1R antagonists aprepitant and rolapitant provide promising alternatives to nucleoside analogs in treating VZV infections, including myelopathy.
Authors: Donald E Campbell; Nancy Raftery; Richard Tustin; Nancy B Tustin; Michelle L Desilvio; Avital Cnaan; Pyone Pyone Aye; Andrew A Lackner; Steven D Douglas Journal: Clin Vaccine Immunol Date: 2006-09-13
Authors: Dallas Jones; Anna Blackmon; C Preston Neff; Brent E Palmer; Don Gilden; Hussain Badani; Maria A Nagel Journal: J Virol Date: 2016-11-14 Impact factor: 5.103
Authors: Miguel Muñoz; Ana González-Ortega; Marisa Rosso; María José Robles-Frias; Andres Carranza; Manuel Vicente Salinas-Martín; Rafael Coveñas Journal: Peptides Date: 2012-09-28 Impact factor: 3.750
Authors: Christy S Niemeyer; Teresa Mescher; Andrew N Bubak; Eva M Medina; James E Hassell; Maria A Nagel Journal: Viruses Date: 2022-03-25 Impact factor: 5.818
Authors: Andrew N Bubak; Christina N Como; Christina M Coughlan; Noah R Johnson; James E Hassell; Teresa Mescher; Christy S Niemeyer; Ravi Mahalingam; Randall J Cohrs; Timothy D Boyd; Huntington Potter; Holger A Russ; Maria A Nagel Journal: J Infect Dis Date: 2020-03-16 Impact factor: 5.226
Authors: Andrew N Bubak; Christina N Como; Anna M Blackmon; Dallas Jones; Maria A Nagel Journal: J Neuroinflammation Date: 2018-11-15 Impact factor: 8.322
Authors: Christina N Como; Andrew N Bubak; Anna M Blackmon; Dallas Jones; Niklaus H Mueller; Richard Davidson; Maria A Nagel Journal: Invest Ophthalmol Vis Sci Date: 2019-02-01 Impact factor: 4.799
Authors: Andrew N Bubak; Christina N Como; James E Hassell; Teresa Mescher; Seth E Frietze; Christy S Niemeyer; Randall J Cohrs; Maria A Nagel Journal: Neurol Neuroimmunol Neuroinflamm Date: 2021-11-10
Authors: Andrew N Bubak; Cheryl Beseler; Christina N Como; Christina M Coughlan; Noah R Johnson; James E Hassell; Anna M Burnet; Teresa Mescher; D Scott Schmid; Colin Coleman; Ravi Mahalingam; Randall J Cohrs; Timothy D Boyd; Huntington Potter; Ali H Shilleh; Holger A Russ; Maria A Nagel Journal: J Infect Dis Date: 2021-04-08 Impact factor: 5.226